IVVD
Invivyd, Inc.
Biopharmaceutical company developing antibody-based therapies for serious viral infectious diseases via its proprietary INVYMAB platform
CUSIP: 00534A102HealthcareUS1 holder
Total Value
$7.31M
Total Shares
10.23M
Net Share Change
-729.5K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$7.31M10.23M shares
TRIM-729.5K(-6.7%)